Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Presented on .

Advances in science and technology aimed at identifying the genetic makeup of microorganisms will build CDC’s capacity to prevent illness and save lives. CDC estimates that 1 in 6 Americans—or 48 million people—get sick from contaminated food each year—costing the United States $77 billion per year in health care treatment, workplace, and other economic losses. Additionally, in the United States, the number of outbreaks involving drug-resistant microbes is on the rise. Although they are still highly valuable, CDC’s current methods are limiting our ability for better and more rapid detection of these microbes.

This session of Grand Rounds explored opportunities for CDC to leverage key aspects of Advanced Molecular Detection (AMD), bioinformatics and enhanced molecular tools, such as whole genome sequence, to improve our ability to diagnose/identify infectious diseases, investigate and control outbreaks, understand transmission patterns, develop and target vaccines, and determine antimicrobial resistance—all with increased timeliness, accuracy and decreased costs.

Beyond the Data

Dr. Tanja Popovic and Dr. Duncan MacCannell discuss the application of Advanced Molecular Detection technologies such as genomic sequencing and bioinformatics. These technologies will yield key benefits to public health such as:

  • Improved Detection
  • More detailed identification of antimicrobial resistance
  • Better Outbreak Investigation

Presented By

Duncan MacCannell, PhD
Senior Advisor for Bioinformatics
National Center for Emerging and Zoonotic Diseases, CDC
James Posey, PhD
Lead, Applied Research Team, Laboratory Branch
Division of Tuberculosis Elimination

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Michael W. Shaw, PhD
Associate Director of Laboratory Science, Influenza Division
National Center for Immunization and Respiratory Diseases, CDC
John R. McQuiston, PhD
Team Lead, Special Bacteriology Reference Laboratory
Bacterial Special Pathogens Branch
Division of High Consequence Pathogens and Pathology

National Center for Emerging and Zoonotic Diseases, CDC
David Engelthaler, MS
Director, TGen North
Translational Genomics Research Institute

Facilitated By

Tanja Popovic, MD, PhD
Scientific Director
John Iskander, MD, MPH
Deputy Scientific Director
Susan Laird, MSN, RN
Communications Director

Enjoyed this Presentation?

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!Sign Up

Sign Up

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

  • Page last reviewed: January 28, 2018
  • Page last updated: January 28, 2018
  • Content source:
    • Office of the Associate Director for Science
    • Page maintained by: Office of the Associate Director for Communication
TOP